Prediction of systemic exposure to cyclosporine in Japanese pediatric patients
Open Access
- 14 September 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Human Genetics
- Vol. 51 (11), 969-976
- https://doi.org/10.1007/s10038-006-0048-7
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Cyclosporine: From Renal Transplantation to Autoimmune DiseasesAnnals of the New York Academy of Sciences, 2005
- Cyclosporin A absorption profiles in children with nephrotic syndromePediatric Nephrology, 2005
- MDR-1 C3435T Polymorphism Influences Cyclosporine A Dose Requirement in Liver-Transplant RecipientsTransplantation, 2004
- MDR1 Haplotypes Do Not Affect the Steady‐State Pharmacokinetics of Cyclosporine in Renal Transplant PatientsThe Journal of Clinical Pharmacology, 2003
- Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients1Transplantation, 2003
- Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising EnzymesClinical Pharmacokinetics, 2003
- Clinical validation studies of neoral C2 monitoring: a reviewTransplantation, 2002
- EDITORIAL COMMENTTransplantation, 2002
- Immunosuppressive Therapy for Paediatric Transplant PatientsClinical Pharmacokinetics, 2002
- Cyclosporin Clinical PharmacokineticsClinical Pharmacokinetics, 1993